Activity Info

This summary provides a recap of the challenges in recognizing and managing atypical hemolytic uremic syndrome (aHUS) in pregnancy and the postpartum period, where clinical overlap with conditions such as HELLP syndrome and thrombotic thrombocytopenic purpura can lead to delayed diagnosis and treatment. Despite advances in understanding complement-mediated pathophysiology and the availability of targeted therapies, gaps in clinical awareness remain and may contribute to significant maternal and fetal morbidity.

Through concise, case-based highlights, this resource offers practical guidance on differentiating aHUS from other thrombotic microangiopathies, applying evidence-based treatment strategies, and supporting a multidisciplinary approach to care to help improve patient outcomes.